475 related articles for article (PubMed ID: 24709861)
1. S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis.
Tomcik M; Palumbo-Zerr K; Zerr P; Avouac J; Dees C; Sumova B; Distler A; Beyer C; Cerezo LA; Becvar R; Distler O; Grigorian M; Schett G; Senolt L; Distler JH
Ann Rheum Dis; 2015 Sep; 74(9):1748-55. PubMed ID: 24709861
[TBL] [Abstract][Full Text] [Related]
2. Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis.
Tomcik M; Palumbo-Zerr K; Zerr P; Sumova B; Avouac J; Dees C; Distler A; Becvar R; Distler O; Schett G; Senolt L; Distler JH
Ann Rheum Dis; 2016 Mar; 75(3):609-16. PubMed ID: 25603829
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis.
Zerr P; Vollath S; Palumbo-Zerr K; Tomcik M; Huang J; Distler A; Beyer C; Dees C; Gela K; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2015 Mar; 74(3):e20. PubMed ID: 24448349
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis.
Tomcik M; Zerr P; Pitkowski J; Palumbo-Zerr K; Avouac J; Distler O; Becvar R; Senolt L; Schett G; Distler JH
Ann Rheum Dis; 2014 Jun; 73(6):1215-22. PubMed ID: 23661493
[TBL] [Abstract][Full Text] [Related]
5. Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis.
Zerr P; Palumbo-Zerr K; Huang J; Tomcik M; Sumova B; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2016 Jan; 75(1):226-33. PubMed ID: 25180292
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc.
Liang R; Šumová B; Cordazzo C; Mallano T; Zhang Y; Wohlfahrt T; Dees C; Ramming A; Krasowska D; Michalska-Jakubus M; Distler O; Schett G; Šenolt L; Distler JH
Ann Rheum Dis; 2017 Apr; 76(4):756-764. PubMed ID: 27793816
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis.
Zhang Y; Pötter S; Chen CW; Liang R; Gelse K; Ludolph I; Horch RE; Distler O; Schett G; Distler JHW; Dees C
Ann Rheum Dis; 2018 May; 77(5):744-751. PubMed ID: 29431122
[TBL] [Abstract][Full Text] [Related]
8. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
9. Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis.
Mallano T; Palumbo-Zerr K; Zerr P; Ramming A; Zeller B; Beyer C; Dees C; Huang J; Hai T; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2016 Mar; 75(3):586-92. PubMed ID: 25589515
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis.
Zhang Y; Dees C; Beyer C; Lin NY; Distler A; Zerr P; Palumbo K; Susok L; Kreuter A; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2015 May; 74(5):936-43. PubMed ID: 24431397
[TBL] [Abstract][Full Text] [Related]
11. Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts.
Ihn H; Yamane K; Asano Y; Jinnin M; Tamaki K
Rheumatology (Oxford); 2006 Feb; 45(2):157-65. PubMed ID: 16319104
[TBL] [Abstract][Full Text] [Related]
12. Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.
Sonnylal S; Denton CP; Zheng B; Keene DR; He R; Adams HP; Vanpelt CS; Geng YJ; Deng JM; Behringer RR; de Crombrugghe B
Arthritis Rheum; 2007 Jan; 56(1):334-44. PubMed ID: 17195237
[TBL] [Abstract][Full Text] [Related]
13. S100A4 expression is increased in stricture fibroblasts from patients with fibrostenosing Crohn's disease and promotes intestinal fibroblast migration.
Cunningham MF; Docherty NG; Burke JP; O'Connell PR
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G457-66. PubMed ID: 20489045
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of sumoylation prevents experimental fibrosis.
Khodzhigorova A; Distler A; Lang V; Dees C; Schneider H; Beyer C; Gelse K; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2012 Nov; 71(11):1904-8. PubMed ID: 22904261
[TBL] [Abstract][Full Text] [Related]
15. Effect of Anti-S100A4 Monoclonal Antibody Treatment on Experimental Skin Fibrosis and Systemic Sclerosis-Specific Transcriptional Signatures in Human Skin.
Trinh-Minh T; Györfi AH; Tomcik M; Tran-Manh C; Zhou X; Dickel N; Tümerdem BS; Kreuter A; Burmann SN; Borchert SV; Hussain RI; Hallén J; Klingelhöfer J; Kunz M; Distler JHW
Arthritis Rheumatol; 2024 May; 76(5):783-795. PubMed ID: 38108109
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
Soare A; Györfi HA; Matei AE; Dees C; Rauber S; Wohlfahrt T; Chen CW; Ludolph I; Horch RE; Bäuerle T; von Hörsten S; Mihai C; Distler O; Ramming A; Schett G; Distler JHW
Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829
[TBL] [Abstract][Full Text] [Related]
17. Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma.
Takagawa S; Lakos G; Mori Y; Yamamoto T; Nishioka K; Varga J
J Invest Dermatol; 2003 Jul; 121(1):41-50. PubMed ID: 12839562
[TBL] [Abstract][Full Text] [Related]
18. Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc.
Liang R; Kagwiria R; Zehender A; Dees C; Bergmann C; Ramming A; Krasowska D; Michalska-Jakubus M; Kreuter A; Kraner ME; Schett G; Distler JHW
Ann Rheum Dis; 2019 Sep; 78(9):1269-1273. PubMed ID: 31177096
[TBL] [Abstract][Full Text] [Related]
19. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
Avouac J; Palumbo K; Tomcik M; Zerr P; Dees C; Horn A; Maurer B; Akhmetshina A; Beyer C; Sadowski A; Schneider H; Shiozawa S; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
